This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database.
Abdel–Kader Martín, L; Castillo Muñoz, MA; Ubago Pérez, R; Vega Coca, MD; Rodríguez López, R. Terapias biológicas en el tratamiento de la anemia asociada a insuficiencia renal crónica: eficacia y seguridad comparada entre los agentes estimuladores de la eritropoyesis. [Biological therapies in the treatment of anaemia associated with chronic kidney disease: a comparison of efficacy and safety of different erythropoiesis-stimulating agents] Seville: Andalusian Agency for Health Technology Assessment (AETSA). AETSA 2012 /3. 2013
To comparatively evaluate the efficacy and safety of the different available ESAs in adult and paediatric patients with anaemia associated with CKD.
In adult patients with anaemia associated with CKD, no significant differences were observed in efficacy between the four ESAs (erythropoietin α, erythropoietin, darbepoetin, and CERA) in terms of patients who reach target Hb levels, require PRBC transfusions, or changes in haemoglobin levels, or safety.
Subject indexing assigned by CRD
Anemia; Erythropoietin; Hematinics; Renal Insufficiency, Chronics
Country of organisation
An English language summary is available.
Address for correspondence
Agencia de Evaluacion de Tecnologias Sanitarias Sanitarias de Andalucia (AETSA) Av/ Luis Montoto No 89 CP 41007 Sevilla (Spain) Tel. +34 955 921 581 Fax + 34 955 923 572 Email: email@example.com
Date abstract record published